HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China
· Delayed Price · Currency is CNY 2.690
+0.150 (5.91%)
May 23, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Chemical Medicine | 2.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemical Medicine Growth | -15.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Traditional Chinese Medicine | 100.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Traditional Chinese Medicine Growth | -24.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 7.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 37.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 784.48K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -52.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Manufacturing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Manufacturing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Agent | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Agent Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 2.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -15.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abroad | 2.36M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abroad Growth | -61.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|